| Date Filed | Type | Description |
| 10/12/2023 |
8-K
| Quarterly results |
| 10/04/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 10/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
| 10/02/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/23/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/09/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 07/28/2023 |
8-K
| Quarterly results |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
10-Q
| Quarterly Report for the period ended May 31, 2023 |
| 06/12/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/12/2023 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 05/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 05/10/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 05/10/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/09/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/28/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 04/14/2023 |
10-Q
| Quarterly Report for the period ended February 28, 2023 |
| 04/03/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 03/22/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/10/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/03/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 02/27/2023 |
4
| TURKEL CATHERINE C. (Director) has filed a Form 4 on Lexaria Bioscience Corp.|
Txns:
| Bought 1,500 shares
@ $2.8446, valued at
$4.3k
|
|
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/23/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 01/18/2023 |
10-Q/A
| Quarterly Report for the period ended November 30, 2022 [amend] |
| 01/17/2023 |
10-Q
| Quarterly Report for the period ended November 30, 2022 |
| 01/17/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 12/30/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/21/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/06/2022 |
10-K/A
| Annual Report for the period ended August 31, 2022 [amend] |
|